Showing results (321-330 of 386) with videos related to

Sort By:
Pageof 39
Journal of Hematotherapy|December 1, 1995
Immunomagnetic selection of CD34+ cells from fresh peripheral blood mononuclear cell preparations using two different separation techniquesC A Papadimitriou, A Roots, M Koenigsmann, et al.
Cancer Research|May 15, 1995
Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologiesM S Topp, C A Papadimitriou, F Eitelbach, et al.
Oncogene|January 19, 2011
Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERGL H Mochmann, J Bock, J Ortiz-Tánchez, et al.
Seminars in Oncology|December 1, 1990
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphomaA D Ho, F Del Valle, R Haas, et al.
International Journal of Oncology|May 17, 2011
Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivoM Topp, M Koenigsmann, A Miresluis, et al.
Neurology and Therapy|October 8, 2025
Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 ImmunityAndrea Harrer, Richard F Radlberger, Beate Buchegger, et al.
Bone Marrow Transplantation|September 1, 1996
Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapyM P Koenigsmann, M Notter, W U Knauf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanomaA Schmittel, M Schmidt-Hieber, P Martus, et al.
Leukemia|August 1, 1994
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)C Fonatsch, H Gudat, E Lengfelder, et al.
Cancer|October 1, 1989
Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphomaA D Ho, F del Valle, H Rückle, et al.
Pageof 39